How did HALO's Q4 earnings surprise investors?
4/5/2025 07:11pm
Halozyme Therapeutics (HALO) reported an earnings per share (EPS) surprise of $0.1 for the fiscal quarter ending December 31, 2024, according to the latest available data. This positive surprise indicates that the company's actual performance exceeded market expectations, likely due to factors such as strong revenue growth, cost management, or strategic initiatives.